MMP9 and diabetes mellitus: Additionally, the expression level of circulating miR-133a-3p is also shown to be significantly down-regulated in patients with diabetes compared with controls (37), which results in the inhibition of human vascular smooth muscle cell proliferation and the induction of cell apoptosis via matrix metalloprotein-9 (MMP-9) (38).